“…In the case of the former, researchers are typically forced to choose between accepting the control limitations set by manufacturers (often necessary to guarantee performance specifications) or designing a bespoke instrument. The community has developed multiple innovative approaches to high-throughput screening and automation (Carragher et al, 2000;Mastronarde, 2003;Schorb et al, 2019), most prominently in the fields of cell biology (Coudray et al, 2011;Yin et al, 2020), medical diagnostics (Gurcan et al, 2009;Martin-Isla et al, 2020), single-particle cryo electron microscopy (Liu et al, 2016;Frank, 2017), but also in crystallography (Rauch & Véron, 2014), semiconductor metrology (Strauss & Williamson, 2013), and particle analysis (House et al, 2017;Uusimaeki et al, 2019). More recently, manufacturers have begun to provide increased access to low-level instrument functions (Meyer et al, 2019;Kalinin et al, 2021;PyJEM).…”